TraceLink Unveils Smart Rx Manager, a Flexible Pharmacy Solution for EU Falsified Medicines Directive (FMD) Compliance
TraceLink announces Smart Rx Manager, a solution that enables pharmacists, hospitals, clinics and dispensing doctors to achieve compliance with the verification and decommissioning requirements of the European Union Falsified Medicines Directive (FMD).
Keynote Speakers Announced for FutureLink Chicago
Dr. Bertalan Mesko, “The Medical Futurist,” and cancer survivor Dave deBronkart, “e-Patient Dave” will deliver the opening and closing keynotes for FutureLink, taking place November 5 – 7 in Chicago. FutureLink will feature over 30 industry presentations and an invitation-only VIP Executive Summit, providing forward-looking, insightful sessions focused on leveraging information-sharing networks to shape the future of the digital drug supply.
TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies
TraceLink now serves over 1,000 customers in 43 countries, delivering proven solutions for companies that are complying with U.S. Drug Supply Chain Security Act (DSCSA), EU Falsified Medicines Directive (FMD) and additional track and trace requirements in Russia, India, South Korea, China and Brazil.
TraceLink Announces Availability of End-to-End DSCSA Saleable Returns Verification Solution for Pharmaceutical Manufacturers and Wholesale Distributors
TraceLink announces the availability of its end-to-end saleable returns verification solution to help pharmaceutical manufacturers and wholesale distributors meet the November 2019 Drug Supply Chain and Security Act (DSCSA) saleable returns requirement.